Extracorporeal membrane oxygenation and inhaled sedation in coronavirus disease 2019-related acute respiratory distress syndrome
| Autor: | Thomas Georg Karl Breuer, Dennis Özcelik, Claudia Steinfort, Thomas P. Weber, Jennifer Herzog-Niescery, Martin Bellgardt, A. Breuer-Kaiser |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Extracorporeal membrane oxygenation
Acute respiratory distress syndrome Coronavirus disease 2019 (COVID-19) business.industry Sedation medicine.medical_treatment COVID-19 Minireviews Acute respiratory distress Critical care Inhaled sedation Anesthesia medicine medicine.symptom business Volatile anesthetics |
| Zdroj: | World Journal of Critical Care Medicine |
| ISSN: | 2220-3141 |
| Popis: | Coronavirus disease 2019 (COVID-19) related acute respiratory distress syndrome (ARDS) is a severe complication of infection with severe acute respiratory syndrome coronavirus 2, and the primary cause of death in the current pandemic. Critically ill patients often undergo extracorporeal membrane oxygenation (ECMO) therapy as the last resort over an extended period. ECMO therapy requires sedation of the patient, which is usually achieved by intravenous administration of sedatives. The shortage of intravenous sedative drugs due to the ongoing pandemic, and attempts to improve treatment outcome for COVID-19 patients, drove the application of inhaled sedation as a promising alternative for sedation during ECMO therapy. Administration of volatile anesthetics requires an appropriate delivery. Commercially available ones are the anesthetic gas reflection systems AnaConDa® and MIRUSTM, and each should be combined with a gas scavenging system. In this review, we describe respiratory management in COVID-19 patients and the procedures for inhaled sedation during ECMO therapy of COVID-19 related ARDS. We focus particularly on the technical details of administration of volatile anesthetics. Furthermore, we describe the advantages of inhaled sedation and volatile anesthetics, and we discuss the limitations as well as the requirements for safe application in the clinical setting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|